XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.24.3

OTHER ASSETS | 9 Months Ended
--- | ---
Sep. 30, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] |
OTHER ASSETS | NOTE 9—OTHER ASSETS The following is a summary of our other assets (dollars in thousands):
| As of September 30, 2024 |  | As of December 31, 2023
Straight-line rent receivables | $ | 203,237 |  |  | $ | 194,108 |
Deferred lease costs, net | 139,537 |  |  | 118,556 |
Investment in unconsolidated operating entities | 88,344 |  |  | 80,312 |
Stock warrants | 65,377 |  |  | 59,281 |
Non-mortgage loans receivable, net | 23,754 |  |  | 26,152 |
Other intangibles, net | 4,953 |  |  | 5,584 |
Other | 278,152 |  |  | 199,417 |
Total other assets | $ | 803,354 |  |  | $ | 683,410 |
In the above table, stock warrants as of September 30, 2024 represent: (1) warrants exercisable at any time prior to December 31, 2025, in whole or in part, for 12.6 million shares of Brookdale Senior Living, Inc. common stock (“Brookdale Common Stock”) at an exercise price of $3.00 per share (the “Brookdale Warrants”), and (2) warrants exercisable at any time prior to September 13, 2034 for 9.9% of the common equity of a parent company of Kindred Healthcare, LLC (“Kindred”) exercisable at the pre-transaction value of such common equity (the “Scion Warrants”). We received the Scion Warrants in September 2024 as part of the consideration for a lease amendment that we entered into with Kindred and its parent companies, ScionHealth. During the nine months ended September 30, 2024, we exercised Brookdale Warrants for 3.7 million shares of Brookdale Common Stock on a cashless basis, resulting in our receipt of 2.1 million shares of Brookdale Common Stock (net of the $3.00 exercise price), which we sold for net cash proceeds of approximately $14.0 million (recorded within operating cash flows in our Consolidated Statements of Cash Flows). The Brookdale Warrants and the Scion Warrants are measured at fair value with changes in fair value being recognized within other expense (income) in our Consolidated Statements of Income.

X
- References No definition available. + Details
Name: | us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_OtherAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration